Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sims

Showing results (701-710 of 711) with videos related to

Pageof 72
Sort By:
The Journal of Molecular Diagnostics : JMD|February 12, 2017
Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical TrialChih-Jian Lih, Robin D Harrington, David J Sims, et al.
ACS Medicinal Chemistry Letters|July 26, 2017
GNE-886: A Potent and Selective Inhibitor of the Cat Eye Syndrome Chromosome Region Candidate 2 Bromodomain (CECR2)Terry D Crawford, James E Audia, Steve Bellon, et al.
The Journal of Biological Chemistry|April 9, 2016
Regulatory T Cell Modulation by CBP/EP300 Bromodomain InhibitionSrimoyee Ghosh, Alexander Taylor, Melissa Chin, et al.
Journal of the National Cancer Institute|January 11, 2020
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial DesignKeith T Flaherty, Robert Gray, Alice Chen, et al.
ACS Medicinal Chemistry Letters|May 19, 2016
Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637)Alexander M Taylor, Alexandre Côté, Michael C Hewitt, et al.
Life Sciences|August 5, 2021
A common language for Gulf War Illness (GWI) research studies: GWI common data elementsDevra E Cohen, Kimberly A Sullivan, Rebecca B McNeil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2025
A Concordance Study among 26 NGS Laboratories Participating in the NCI Molecular Analysis for Therapy Choice Clinical TrialLinda K Zane, Laura M Yee, Ting-Chia Chang, et al.
Physical Review Letters|June 1, 2004
Measurement of the total active 8B solar neutrino flux at the Sudbury Neutrino Observatory with enhanced neutral current sensitivityS N Ahmed, A E Anthony, E W Beier, et al.
Physical Review Letters|April 20, 2004
Constraints on nucleon decay via invisible modes from the Sudbury Neutrino ObservatoryS N Ahmed, A E Anthony, E W Beier, et al.
Physical Review Letters|July 5, 2002
Direct evidence for neutrino flavor transformation from neutral-current interactions in the Sudbury Neutrino ObservatoryQ R Ahmad, R C Allen, T C Andersen, et al.
Pageof 72

Showing results (701-710 of 711) with videos related to

Sort By:
Pageof 72
The Journal of Molecular Diagnostics : JMD|February 12, 2017
Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical TrialChih-Jian Lih, Robin D Harrington, David J Sims, et al.
ACS Medicinal Chemistry Letters|July 26, 2017
GNE-886: A Potent and Selective Inhibitor of the Cat Eye Syndrome Chromosome Region Candidate 2 Bromodomain (CECR2)Terry D Crawford, James E Audia, Steve Bellon, et al.
The Journal of Biological Chemistry|April 9, 2016
Regulatory T Cell Modulation by CBP/EP300 Bromodomain InhibitionSrimoyee Ghosh, Alexander Taylor, Melissa Chin, et al.
Journal of the National Cancer Institute|January 11, 2020
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial DesignKeith T Flaherty, Robert Gray, Alice Chen, et al.
ACS Medicinal Chemistry Letters|May 19, 2016
Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637)Alexander M Taylor, Alexandre Côté, Michael C Hewitt, et al.
Life Sciences|August 5, 2021
A common language for Gulf War Illness (GWI) research studies: GWI common data elementsDevra E Cohen, Kimberly A Sullivan, Rebecca B McNeil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2025
A Concordance Study among 26 NGS Laboratories Participating in the NCI Molecular Analysis for Therapy Choice Clinical TrialLinda K Zane, Laura M Yee, Ting-Chia Chang, et al.
Physical Review Letters|June 1, 2004
Measurement of the total active 8B solar neutrino flux at the Sudbury Neutrino Observatory with enhanced neutral current sensitivityS N Ahmed, A E Anthony, E W Beier, et al.
Physical Review Letters|April 20, 2004
Constraints on nucleon decay via invisible modes from the Sudbury Neutrino ObservatoryS N Ahmed, A E Anthony, E W Beier, et al.
Physical Review Letters|July 5, 2002
Direct evidence for neutrino flavor transformation from neutral-current interactions in the Sudbury Neutrino ObservatoryQ R Ahmad, R C Allen, T C Andersen, et al.
Pageof 72